Compare · 2 funds side by side · dividends reinvested

LABD and SCHD

LABDDirexion×SCHDSchwab×

Versus in desk

02 / 04

IWD+0.4%

Search ETFs and stocks

Portfolio

Story of the two · Growth3Y$10,000 three years agoDividends reinvested · both on one scale$17,234SCHD · best of the two

Story of the two · IncomeMost incomeLABD · 6.91% · $691 a year on $10k

Story of the two · RiskSmallest drop

LABD and SCHD, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Schwab U.S. Dividend Equity ETFIncome · Dividend stocks0.06%2.93%+34.6%+39.3%+19.9%+10.4%−6.9%11.8%$123B1.1

Direxion Daily S&P Biotech Bear 3X ETFLeveraged · An index1.08%6.91%−67.7%−77.1%−67.8%−46.1%−79.9%91.0%$70M1.9

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 11, 2026 · returns include dividends · since: LABD 2015 · SCHD 2011

Head to Head

Swap sides Versus in desk

Head to Head

5Y

Direxion Daily S&P Biotech Bear 3X ETF · $70M$454

LABD

SCHD

Schwab U.S. Dividend Equity ETF · $123B$16,418

$10,000 five years ago, dividends reinvested

LABDMeasureSCHD

−67.7%

More Ways to See the Pairs

LABD vs SCHD: Top 5 Holdings

Today

LABD

[…]in top 5

SCHD

in top 521.7%

LABDStockSCHD

not top 5TXN4.6%

not top 5PG4.4%

not top 5HD4.3%

not top 5KO4.3%

not top 5AMGN4.1%

Cost, Income and Risk

Fees: LABD, SCHD

Today

0.06%lowest, SCHD

FundExpense ratioFee$10k

SCHD0.06%$6

LABD1.08%$108

End-of-day Nov 11, 2026 · fee on $10,000 a year

Yields: LABD, SCHD

1Y

6.91%highest, LABD

FundTrailing yield

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+34.6%

VIGVanguard

+16.0%

+34.6%Year to date+16.0%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 11, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.1%

JEPIJ.P. Morgan

+8.6%

SPYM vs SPY

YTD

SPDRSPYM

+12.4%

SPYSPDR

+12.3%

Year to dateJan 1 → Nov 11

+34.6%

−77.1%1 yearTotal return+39.3%

−67.8%3 years · per year$10,000 became $334 · $17,234+19.9%

−46.1%5 years · per year$10,000 became $454 · $16,418+10.4%

1.08%Expense ratio$108 · $6 a year on $10k · lower is better0.06%

6.91%Trailing 12-mo yield$691 · $293 a year on $10k2.93%

−79.9%Worst dropSmaller is better−6.9%

91.0%VolatilityLower is calmer11.8%

LABDSCHD Winner of the row, in its colourEach row: the bigger of the two fills its side

1–7SCHD wins

End-of-day Nov 11, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

Held in common[…]

End-of-day Nov 11, 2026 · share of each fund

LABD vs SCHD Returns, Every Period

5Y

DirexionLABD

−46.1%

5 years, per year

SCHDSchwab

+10.4%

5 years, per year

LABDSCHDFaded: behind in that period

0–4SCHD wins

End-of-day Nov 11, 2026 · dividends in · faded = behind in that period

Leveraged vs Income: LABD vs SCHD

YTD

DirexionLABD

−67.7%

SCHDSchwab

+34.6%

−67.7%Year to date+34.6%

−79.9%Worst drop · 1Y−6.9%

91.0%Volatility · 1Y11.8%

6.9%Yield2.9%

$70.1MAssets$123B

3–1SCHD wins

End-of-day Nov 11, 2026 · smaller drop and lower volatility win

Yield

$10k

LABD6.91%$691

SCHD2.93%$293

End-of-day Nov 11, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$583most kept, LABD

LABD$691 − $108 = $583

SCHD$293 − $6 = $287

KeptFee

End-of-day Nov 11, 2026 · yield in dollars minus the fee

Overlap: LABD, SCHD

Today

[…]holdings […]

LABDSCHD

LABD—[…]

SCHD[…]—

End-of-day Nov 11, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+39.3%SCHD, at 11.8% volatility

SCHDWorst drop−6.9%11.8% vol

LABDWorst drop−79.9%91.0% vol

End-of-day Nov 11, 2026 · up and left is better

Paid More vs Made More

YTD

LABDSCHD

−67.7%Year to date+34.6%

6.9%Yield2.9%

−77.1%Past year+39.3%

1.08%Fee0.06%

3–1SCHD wins

End-of-day Nov 11, 2026

+8.1%Year to date+8.6%

12.2%Yield7.8%

$41.8BAssets$46.8B

1–1level

End-of-day Nov 11, 2026

+12.4%Year to date+12.3%

1.0%Yield1.0%

$183BAssets$793B

1–0SPYM wins

End-of-day Nov 11, 2026

Loading…

LABD and SCHD

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two